Enhancement and external validation of algorithms using diagnosis codes to identify invasive Escherichia coli disease

被引:1
|
作者
Hernandez-Pastor, Luis [1 ]
Geurtsen, Jeroen [2 ]
El Khoury, Antoine C. [3 ]
Fortin, Stephen P. [4 ]
Gauthier-Loiselle, Marjolaine [5 ,6 ]
Yu, Louise H. [5 ]
Cloutier, Martin [5 ]
机构
[1] Janssen Pharmaceut NV, Beerse, Belgium
[2] Janssen Vaccines & Prevent BV, Leiden, Netherlands
[3] Janssen Global Serv LLC, Raritan, NJ USA
[4] Janssen Res & Dev LLC, Raritan, NJ USA
[5] Anal Grp Inc, Montreal, PQ, Canada
[6] Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte,Suite, Montreal, PQ H3B 0M7, Canada
关键词
Escherichia coli; invasive E. coli disease; sepsis; diagnosis codes; electronic health record database; SEPSIS; TRENDS;
D O I
10.1080/03007995.2023.2247968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the predictive accuracy of code-based algorithms for identifying invasive Escherichia coli (E. coli) disease (IED) among inpatient encounters in US hospitals.Methods: The PINC AI Healthcare Database (10/01/2015-03/31/2020) was used to assess the performance of six published code-based algorithms to identify IED cases among inpatient encounters. Case-confirmed IEDs were identified based on microbiological confirmation of E. coli in a normally sterile body site (Group 1) or in urine with signs of sepsis (Group 2). Code-based algorithm performance was assessed overall, and separately for Group 1 and Group 2 based on sensitivity, specificity, positive and negative predictive value (PPV and NPV) and F1 score. The improvement in performance of refinements to the best-performing algorithm was also assessed.Results: Among 2,595,983 encounters, 97,453 (3.8%) were case-confirmed IED (Group 1: 60.9%; Group 2: 39.1%). Across algorithms, specificity and NPV were excellent (>97%) for all but one algorithm, but there was a trade-off between sensitivity and PPV. The algorithm with the most balanced performance characteristics included diagnosis codes for: (1) infectious disease due to E. coli OR (2) sepsis/bacteremia/organ dysfunction combined with unspecified E. coli infection and no other concomitant non-E. coli invasive disease (sensitivity: 56.9%; PPV: 56.4%). Across subgroups, the algorithms achieved lower algorithm performance for Group 2 (sensitivity: 9.9%-61.1%; PPV: 3.8%-16.0%).Conclusions: This study assessed code-based algorithms to identify IED during inpatient encounters in a large US hospital database. Such algorithms could be useful to identify IED in healthcare databases that lack information on microbiology data.
引用
收藏
页码:1303 / 1312
页数:10
相关论文
共 44 条
  • [1] Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease
    Fortin, Stephen P.
    Pastor, Luis Hernandez
    Doua, Joachim
    Sarnecki, Michal
    Swerdel, Joel
    Colasurdo, Jamie
    Geurtsen, Jeroen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (09) : 983 - 991
  • [2] Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning
    Clarke, Erik
    Chehoud, Christel
    Khan, Najat
    Spiessens, Bart
    Poolman, Jan
    Geurtsen, Jeroen
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [3] Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals
    Doua, Joachim
    Geurtsen, Jeroen
    Rodriguez-Bano, Jesus
    Cornely, Oliver A.
    Go, Oscar
    Gomila-Grange, Aina
    Kirby, Andrew
    Hermans, Peter
    Gori, Andrea
    Zuccaro, Valentina
    Gravenstein, Stefan
    Bonten, Marc
    Poolman, Jan
    Sarnecki, Michal
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (02):
  • [4] Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United States
    Schmidt, Mark A.
    Blum, Maxim
    Donald, Judy L.
    Meenan, Richard T.
    Carrio, Elvira
    Poolman, Jan
    Neary, Maureen P.
    Verstraeten, Thomas
    Geurtsen, Jeroen
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (03) : 569 - 586
  • [5] Invasive Escherichia coli are a feature of Crohn's disease
    Sasaki, Maiko
    Sitaraman, Shanti V.
    Babbin, Brian A.
    Gerner-Smidt, Peter
    Ribot, Efrain M.
    Garrett, Nancy
    Alpern, Joel A.
    Akyildiz, Adil
    Theiss, Arianne L.
    Nusrat, Asma
    Klapproth, Jan-Michael A.
    LABORATORY INVESTIGATION, 2007, 87 (10) : 1042 - 1054
  • [6] Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017
    Blum, Maxim
    Geurtsen, Jeroen
    Herweijer, Eva
    Sarnecki, Michal
    Spiessens, Bart
    Diogo, Gil Reynolds
    Hermans, Peter
    Thelwall, Simon
    Bhattacharya, Alex
    Verstraeten, Thomas
    Poolman, Jan
    Hope, Russell
    EPIDEMIOLOGY & INFECTION, 2025, 153
  • [7] Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States
    Hernandez-Pastor, Luis
    Geurtsen, Jeroen
    Baugh, Bryan
    El Khoury, Antoine C.
    Kalu, Nnanya
    Gauthier-Loiselle, Marjolaine
    Bungay, Rebecca
    Cloutier, Martin
    Sarnecki, Michal
    Saade, Elie
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [8] Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States
    Hernandez-Pastor, Luis
    Geurtsen, Jeroen
    Baugh, Bryan
    Khoury, Antoine C. El
    Kalu, Nnanya
    Krishnarajah, Girishanthy
    Gauthier-Loiselle, Marjolaine
    Bungay, Rebecca
    Cloutier, Martin
    Saade, Elie
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (08) : 873 - 883
  • [9] Development and external validation of tools for categorizing diagnosis codes in international hospital data
    Malecki, Sarah L.
    Loffler, Anne
    Tamming, Daniel
    Johansen, Niklas Dyrby
    Biering-Sorensen, Tor
    Fralick, Michael
    Sohail, Shahmir
    Shi, Jessica
    Roberts, Surain B.
    Colacci, Michael
    Ismail, Marwa
    Razak, Fahad
    Verma, Amol A.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2024, 189
  • [10] Impact of Invasive Escherichia Coli Disease on Clinical Outcomes and Medical Resource Utilization Among Asian Patients in the United States
    Zhuo, Chao
    Zheng, Bo
    Wattanakamolkul, Kittima
    Nakayama, Yoshikazu
    Cloutier, Martin
    Gauthier-Loiselle, Marjolaine
    Feng, Jun
    Wu, David
    Neary, Maureen P.
    Geurtsen, Jeroen
    El Khoury, Antoine C.
    Gu, Yoshiaki
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (02) : 313 - 328